Botox approved for crow's feet

The licence for Botox has been extended

The licence for Botox (botulinum toxin type A) has been extended to include temporary improvement in the appearance of moderate to severe crow's feet seen at maximum smile, when these have an important psychological impact.1

Botox is reconstituted to a concentration of 50 units/1.5ml, and three 0.1ml injections are given into the lateral orbicularis oculi muscle on each side, for a total dose of 24 units. For patients who also have glabellar lines causing psychological effects, these may be treated at the same time.1

Improvement generally occurs within one week after treatment and lasts for up to four months. Treatment intervals should not be less than three months.1

Reference

1. Botox Summary of Product Characteristics, January 2014.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...